medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
泌尿外科指南
检索结果
人体系统
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
良性前列腺增生
前列腺肿瘤
睾丸肿瘤
阴茎癌
泌尿生殖肿瘤
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
7条
与
Patients
有关的结果
Kidney Cancer(Guideline for Patients)
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
泌尿
|
肾癌
National Comprehensive Cancer Network
Patients
Kidney Cancer
stating
testing
treatment
指南简介
原文链接
Prostate Cancer: Advanced Stage(Guideline for Patients)
2021年 发布于
National Comprehensive Cancer Network
卷 第期
所属人体系统：
生殖
|
前列腺肿瘤
National Comprehensive Cancer Network
Patients
Prostate Cancer
staging
treatment
recurrence
指南简介
原文链接
European Association of Urology Guidelines on Renal Cell Carcinoma: the 2019 Update
2019年 发布于
Eur Urol
75卷 第5期
所属人体系统：
泌尿
|
肾癌
European Association of Urology
The European Association of Urology Renal Cell Carcinoma Guideline Panel Has Thoroughly Evaluated the Available Research Data on Kidney Cancer to Establish International Standards for the Care of Kidney Cancer
Patients
指南简介
原文链接
Consensus on Management of Castration-resistant Prostate Cancer on Behalf of the Urological Tumours Working Group (URONCOR) of the Spanish Society of Radiation Oncology
2019年 发布于
Clin Transl Oncol
21卷 第1期
所属人体系统：
生殖
|
前列腺肿瘤
Urological Tumours Working Group
Ablative Treatments
Chemotherapy
Colorectal Cancer
Frail
Patients
Metastases
Surgery
Targeted Agents
指南简介
原文链接
Updated Recommendations of the International Society of Geriatric Oncology on Prostate Cancer Management in Older Patients
2019年 发布于
Eur J Cancer
116卷 第—期
所属人体系统：
生殖
|
前列腺肿瘤
International Society of Geriatric Oncology
Geriatric Evaluation
Older
Patients
Prostate Cancer
Treatment
指南简介
原文链接
German S3 Guideline for Renal Cell Carcinoma : Presentation and Discussion of Essential Aspects for the Radiation Oncologist
2018年 发布于
Strahlenther Onkol
194卷 第1期
所属人体系统：
泌尿
|
肾癌
无
Purpose: We Aim to Introduce and Discuss the Statements and Recommendations of the German S3 Guideline on Renal Cell Cancer for Daily Practice of Radiation Oncologists
Methods: This Report Comprises Indication
Treatment Decision
Dose Prescription and Current Literature Including Treatment of Oligometastatic Disease
Results: According to Different Stages of the Disease and the Structure of the Guideline We Focus on Five Treatment Situations and Recommendations for Decision Making: (1) Neo-/adjuvant Treatment Before Or after Nephrectomy: No Indication for Radiotherapy (2) Small Renal Mass: Stereotactic Ablative Radiotherapy Is Currently Seen as Experimental Option due to Small Patient Numbers Reported in the Literature However
Local Tumor Control Achieved by SBRT Appears Favourable with >90% at 2 Years (3) Oligometastasis: Radiation Treatment with Higher Local Doses Or Stereotactic Treatment Is Possible after Interdisciplinary Discussion Indications for Palliative (4) and Symptomatic Treatment (5) Are Not Different Compared to Other Tumor Entities
Conclusion: Currently
There Is No Evidence-based Indication for Radiation Treatment in the Primary Setting (adjuvant/neoadjuvant Or Definitive) of Renal Cell Cancer in the Future Stereotactic Radiotherapy Should Have a Stronger Role in the Treatment of Medically Inoperable
Patients
with Primary Renal Cell Cancer and Especially in the Setting of Oligometastasis
指南简介
原文链接
Elderly Patients with Metastatic Renal Cell Carcinoma: Position Paper from the International Society of Geriatric Oncology
2018年 发布于
Lancet Oncol
19卷 第6期
所属人体系统：
泌尿
|
肾癌
International Society of Geriatric Oncology
Elderly
Patients
Metastatic Renal Cell Carcinoma
指南简介
原文链接
